Peralkylated oligopeptide mixtures
AssigneeHoughten Pharmaceuticals, Inc.
InventorsRichard A. Houghten, John M. Ostresh, Sylvie Blondelle
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoughten Pharmaceuticals, Inc.
InventorsRichard A. Houghten, John M. Ostresh, Sylvie Blondelle
Estimating the term…
Linear C.sub.1 -C.sub.7 -alkyl peralkylated oligopeptide sets of molecules are specific peralkylated oligopeptides, disclosed, as are their methods of synthesis and use in acceptor binding assays. Each molecule or chain of a set contains the same number of two to about ten substituted C.sub.1 -C.sub.7 -alkyl peralkylated amino acid residues, and the member chains of a set are present in equimolar amounts. The chains of a set contain one or more predetermined peralkylated amino acid residues at one or more predetermined positions of the peralkylated oligopeptide chain. The set contains equimolar amounts of at least six different peralkylated amino acid residues at one or more of the same predetermined positions of the peralkylated oligopeptide chain. Libraries of such sets, processes for their use and solid support-linked peralkylated sets are also contemplated, as are specific permethylated oligopeptides such as those having 5-8 phenylalanine residues that have antimicrobial properties.
A permethylated oligopeptide having the formula
A permethylated oligopeptide having 5 to 8 phenylalanine residues, wherein the -N-terminal is a trimethylammonium group and the C-terminal is a N-methylamido group.
Dependencies are inferred from the claim text.